Circulating Oncometabolite 2-Hydroxyglutarate Is a Potential Surrogate Biomarker in Patients with Isocitrate Dehydrogenase-Mutant Intrahepatic CholangiocarcinomaDarrell R. Borger, Andrew X. Zhu, Lipika Goyal et al.|Clinical Cancer Research|2014Cited by 138
Isocitrate Dehydrogenase 1 (<i>IDH1</i>) Mutation in Breast Adenocarcinoma Is Associated With Elevated Levels of Serum and Urine 2-HydroxyglutarateAmir T. Fathi, Darrell R. Borger, Hossein Sadrzadeh et al.|The Oncologist|2014Cited by 74
Decreased activity and stability of pyruvate kinase in sickle cell disease: a novel target for mitapivat therapyMinke A.E. Rab, Richard van Wijk, Jennifer Bos et al.|Blood|2021Cited by 46
AG-221, an Oral, Selective, First-in-Class, Potent IDH2-R140Q Mutant Inhibitor, Induces Differentiation in a Xenotransplant ModelCyril Quivoron, Virginie Penard‐Lacronique, Olivia Bawa et al.|Blood|2014Cited by 19